Guangzhou Innogen Pharmaceutl Grp Co Ltd
Status: Publicly traded
Direct answer
Guangzhou Innogen Pharmaceutl Grp Co Ltd is publicly traded on HKSE under the ticker 2591.HK.
Guangzhou Innogen Pharmaceutical Group Co Ltd operates as a China-based investment holding firm with a core mission to research, develop, and bring to market medicinal products. The company specializes in producing innovative, human-compatible, and extended-duration GLP-1 receptor agonists, specifically targeting the treatment of diabetes and other metabolic conditions.
Can you invest in Guangzhou Innogen Pharmaceutl Grp Co Ltd?
Yes. Guangzhou Innogen Pharmaceutl Grp Co Ltd trades publicly on HKSE as 2591.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Guangzhou Innogen Pharmaceutl Grp Co Ltd
Detailed equity research is provided by MarketSnap.